OLMA Institutional Ownership

OLEMA PHARMACEUTICALS INC

Latest close $11.66 as of Aug 5, 2026

Create account to watch
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.
Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing Jul 29, 2026
Public consensus preview Accumulation leaning 70/100 institutional research score
2 tracked institutions Latest filing Jul 29, 2026

1 accumulating across 1 comparable institution.

Accumulating1
Unchanged0
Reducing0
Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$4.12 52-week high$36.26
Latest close $11.66 23.4% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Jun 30, 2026
Fidelity / FMR Mar 6, 2026 filed
BlackRock Jul 29, 2026 filed
Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 4 parsed filing(s) · 1 older require more history access
Holder Observed / filed Reported change Shares Ownership Observation Filing Latest
BlackRock CIK0002012383 Jun 30, 2026 observed Jul 29, 2026 filed · 29d Schedule 13G amendment Earliest Schedule 13G amendment found 6.2M 12.00% $12.51 $11.19 $11.66
Fidelity / FMR CIK0000315066 Feb 27, 2026 observed Mar 6, 2026 filed · 7d Schedule 13G amendment Reported accumulation 10.0K +5.0K 12.50% +0.50 pts $24.20 $21.55 $11.66
Fidelity / FMR CIK0000315066 Dec 31, 2025 observed Feb 5, 2026 filed · 36d Initial Schedule 13G Initial Schedule 13G 5.0K 12.00% $25.00 $25.01 $11.66
Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

VOR VOR BIOPHARMA INC 70/100 Accumulation leaning TRVI TREVI THERAPEUTICS INC 70/100 Accumulation leaning ZVRA ZEVRA THERAPEUTICS, INC. 70/100 Accumulation leaning SPCE VIRGIN GALACTIC HOLDINGS INC 70/100 Accumulation leaning

Recent multi-institution accumulation

TVTX Travere Therapeutics, Inc. 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026